Our life-changing technologies are shaping the future of structural heart disease with leading transcatheter mitral, tricuspid and aortic valve solutions, stroke prevention and congenital products, as well as surgical valves.

With over 20+ years of clinical experience, our Amplatzer™ occluders are built for every age and define the broadest structural interventions portfolio to date with the most comprehensive size range, designed specifically for stroke-prevention & congenital heart disease.